Objective
Telomere shortening occurs as an early event in pancreatic tumorigenesis and genetic variants at the telomerase reverse transcriptase (TERT) gene region have been associated with pancreatic cancer risk. However, it is unknown whether prediagnostic leukocyte telomere length is associated with subsequent risk of pancreatic cancer.
Design
We measured prediagnostic leukocyte telomere length in 386 pancreatic cancer cases and 896 matched controls from five prospective U.S. cohorts. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using conditional logistic regression. Matching factors included year of birth, cohort (which also matches on sex), smoking status, fasting status, and month/year of blood collection. We additionally examined single nucleotide polymorphisms (SNPs) at the TERT region in relation to pancreatic cancer risk and leukocyte telomere length, using logistic and linear regression, respectively.
Results
Shorter prediagnostic leukocyte telomere length was associated with higher risk of pancreatic cancer (comparing extreme quintiles of telomere length, OR, 1.72; 95% CI, 1.07–2.78; Ptrend=0.048). Results remained unchanged after adjustment for diabetes, body-mass index, and physical activity. Three SNPs at TERT (linkage disequilibrium r2<0.25) were associated with pancreatic cancer risk, including rs401681 (per minor allele OR, 1.33; 95% CI, 1.12–1.59; P=0.002), rs2736100 (per minor allele OR, 1.36; 95% CI, 1.13–1.63; P=0.001), and rs2736098 (per minor allele OR, 0.75; 95% CI, 0.63–0.90; P=0.002). The minor allele for rs401681 was associated with shorter telomere length (P=0.023).
Conclusion
Prediagnostic leukocyte telomere length and genetic variants at the TERT gene region were associated with risk of pancreatic cancer.